Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)

• Access to computer or smartphone

• Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)

Locations
Other Locations
Belgium
University Hospitals Leuven
RECRUITING
Leuven
Contact Information
Primary
Stijn Vanstraelen, MD
stijn.vanstraelen@kuleuven.be
16346822
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 2200
Treatments
Experimental: Survey participants
Participants who will complete a survey investigating their preference for diagnosis and assessment of gastro-esophageal cancer
Related Therapeutic Areas
Sponsors
Leads: KU Leuven

This content was sourced from clinicaltrials.gov